- Home
- BLFS vs QDEL Comparison
BLFS vs QDEL Comparison
Compare BLFS & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLFS
- QDEL
- Stock Information
- Founded
- BLFS 1987
- QDEL 1979
- Country
- BLFS United States
- QDEL United States
- Employees
- BLFS N/A
- QDEL N/A
- Industry
- BLFS Medical/Dental Instruments
- QDEL Medical Specialities
- Sector
- BLFS Health Care
- QDEL Health Care
- Exchange
- BLFS Nasdaq
- QDEL Nasdaq
- Market Cap
- BLFS 1.3B
- QDEL 1.4B
- IPO Year
- BLFS 1989
- QDEL N/A
- Fundamental
- Price
- BLFS $24.10
- QDEL $21.14
- Analyst Decision
- BLFS Strong Buy
- QDEL Hold
- Analyst Count
- BLFS 5
- QDEL 6
- Target Price
- BLFS $30.60
- QDEL $39.33
- AVG Volume (30 Days)
- BLFS 327.5K
- QDEL 1.7M
- Earning Date
- BLFS 11-06-2025
- QDEL 11-05-2025
- Dividend Yield
- BLFS N/A
- QDEL N/A
- EPS Growth
- BLFS N/A
- QDEL N/A
- EPS
- BLFS N/A
- QDEL N/A
- Revenue
- BLFS $100,144,000.00
- QDEL $2,714,400,000.00
- Revenue This Year
- BLFS $25.65
- QDEL N/A
- Revenue Next Year
- BLFS $14.81
- QDEL $2.65
- P/E Ratio
- BLFS N/A
- QDEL N/A
- Revenue Growth
- BLFS 87.53
- QDEL N/A
- 52 Week Low
- BLFS $19.10
- QDEL $19.50
- 52 Week High
- BLFS $29.62
- QDEL $49.45
- Technical
- Relative Strength Index (RSI)
- BLFS 33.03
- QDEL 33.76
- Support Level
- BLFS $25.49
- QDEL $20.42
- Resistance Level
- BLFS $28.21
- QDEL $23.25
- Average True Range (ATR)
- BLFS 1.00
- QDEL 1.70
- MACD
- BLFS -0.44
- QDEL -0.48
- Stochastic Oscillator
- BLFS 8.19
- QDEL 17.52
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
About QDEL QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.